ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

AMRX Amneal Pharmaceuticals Holding Co

5,87
0,00 (0,00%)
Pré-mercado
Última atualização: 21:00:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Amneal Pharmaceuticals Holding Co AMRX NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 5,87 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
5,87
mais cotações »

Notícias Recentes

Data Hora Fonte Título
05/06/202409:00BWAmneal Expands Broad Injectables Portfolio to Over 40..
22/05/202417:05BWAmneal Begins Supplying Over-the-Counter Naloxone..
03/05/202407:00BWAmneal Reports First Quarter 2024 Financial Results
24/04/202409:00BWAmneal Announces U.S. FDA Approval of Over-the-Counter..
16/04/202409:00BWAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version..
10/04/202409:00BWAmneal to Report First Quarter 2024 Results on May 3, 2024
28/03/202417:05BWAmneal to Ring the Nasdaq Closing Bell on April 2, 2024
25/03/202417:05BWAmneal Receives U.S. FDA Approval for Ciprofloxacin and..
01/03/202408:00BWAmneal Reports Fourth Quarter and Full Year 2023 Financial..
27/02/202410:00BWAmneal Enters into Exclusive European Licensing Agreement..
13/02/202410:00BWAmneal to Participate at Upcoming Investor Conference
08/02/202418:05GLOBEAmneal Announces Complete Response Resubmission for IPX203..
31/01/202418:05BWAmneal to Report Fourth Quarter and Full Year 2023 Results..
10/01/202410:00BWAmneal Launches Complex Generic Fluorometholone Ophthalmic..
04/01/202418:05BWAmneal Launched Record Number of 39 New Retail and..
21/12/202310:00BWAmneal to Participate at the 42nd Annual J.P. Morgan..
15/12/202318:05BWAmneal Announces Move to Nasdaq
07/12/202310:00BWAmneal and BIAL Announce U.S. Licensing Agreement for..
01/12/202310:00BWAmneal Expands Portfolio with Addition of Icosapent Ethyl..
07/11/202308:00BWAmneal Reports Third Quarter 2023 Financial Results
03/11/202309:00BWAmneal to Participate at Upcoming Investor Conferences
23/10/202317:05BWAmneal Reports Certain Preliminary Third Quarter 2023..
12/10/202309:00BWAmneal Adds Two Denosumab Biosimilars to U.S. Pipeline,..
05/10/202309:00BWAmneal to Report Third Quarter 2023 Results on November 7,..
06/09/202317:00BWAmneal Receives U.S. FDA Approval for Calcium Gluconate..
06/09/202309:01BW Amneal Receives First Product Approval in China
06/09/202309:00BW Amneal Receives U.S. FDA Approval for Lisdexamfetamine..
29/08/202317:01BWDelegation from U.S. Department of Health and Human..
25/08/202309:00BWAmneal to Participate at the 2023 Wells Fargo Healthcare..
24/08/202317:01BWJAMA Neurology Publishes Phase 3 Study Results Comparing..
04/08/202307:00BWAmneal Reports Second Quarter 2023 Financial Results
26/07/202309:00BWAmneal Submits Abbreviated New Drug Applications to U.S. FDA..
06/07/202309:00BWAmneal to Report Second Quarter 2023 Results on August 4,..
05/07/202311:36DJNAmneal Pharmaceuticals Shares Slide 16% After FDA Rejects..
03/07/202317:13DJNAmneal Pharmaceuticals: FDA Requests Additional Information..
03/07/202316:09DJNAmneal Pharma Receives Approvals for Generic Drug..
03/07/202315:01BWAmneal Launches Authorized Generic for Xyrem® (sodium..
03/07/202315:00BWAmneal Receives U.S. FDA Complete Response Letter for IPX203